| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/26/2001 | WO2000045176A3 METHOD OF IDENTIFYING N-TERMINAL proBNP |
| 07/26/2001 | WO2000043791A3 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases |
| 07/26/2001 | WO2000042182A9 Mammalian cortexin-like proteins and polynucleotides encoding the same |
| 07/26/2001 | WO2000041566A9 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2001 | WO2000040616A9 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41 |
| 07/26/2001 | WO2000026388A9 Novel expression cassette for expressing genes in plant seed |
| 07/26/2001 | WO2000017361A3 Interferon-epsilon |
| 07/26/2001 | US20010009959 Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies |
| 07/26/2001 | US20010009905 Adipocyte Complement-Related Protein encoded polypeptides, used in therapy and diagnosis, cell proliferation, cell death, energy homestasis; treatment of cancers, obesity, diabetes, heart disease, immunity |
| 07/26/2001 | US20010009899 Process for the preparation of pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects |
| 07/26/2001 | US20010009772 Transfecting cell with first polynucleotide comprising retroviral genome operably linked to first inducible transcription regulation element wherein retroviral genome is defective for self-replication, second, third polynucleotides |
| 07/26/2001 | US20010009768 Polynucleotides encoding cytokine designated LERK-5 |
| 07/26/2001 | US20010009766 Dna encoding galanin galr3 receptors and uses thereof |
| 07/26/2001 | US20010009764 Endothelial-derived toxic factor |
| 07/26/2001 | US20010009675 Keratin-based hydrogel for biomedical applications and method of production |
| 07/26/2001 | US20010009667 Method of detecting nucleic acid encoding a retrovirus using polymerase chain reaction (pcr) |
| 07/26/2001 | US20010009666 Acellular pertussis vaccines and methods of preparation thereof |
| 07/26/2001 | DE19953167A1 Mit TRP-Proteinen verwandtes Protein MTR1 und dieses codierende DNA-Sequenz With TRP proteins related protein MTR1 and this DNA sequence encoding |
| 07/26/2001 | DE10001975A1 Non-human mammal with altered inducing functions for the glucocorticoid receptor, useful for testing e.g. therapeutic agents, also has altered c-Fos activity |
| 07/26/2001 | DE10001169A1 New regulatory sequences from the fascin gene, useful for providing dendritic cell-specific expression of e.g. antigens, e.g. for vaccination against tumors and infections |
| 07/26/2001 | DE10001113A1 Recombinant human histone protein, useful e.g. as anticancer or antibiotic agent, expressed in prokaryotic cells |
| 07/26/2001 | DE10000651A1 Identifying inhibitors and activators of eukaryotic potassium channels, for use as pharmaceuticals, comprises using yeast cells that express heterologous, but no endogenous, potassium channels |
| 07/26/2001 | CA2743326A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 07/26/2001 | CA2479511A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | CA2479498A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | CA2402831A1 Prime-boost vaccination strategy |
| 07/26/2001 | CA2402563A1 Novel nucleic acids and polypeptides |
| 07/26/2001 | CA2398710A1 Egg specific surface proteins |
| 07/26/2001 | CA2398695A1 Chondromodulin-i related peptide |
| 07/26/2001 | CA2398605A1 Methods for the purification and aqueous fiber spinning of spider silks and other structural proteins |
| 07/26/2001 | CA2398243A1 Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease |
| 07/26/2001 | CA2398083A1 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 07/26/2001 | CA2397946A1 Lipid metabolism enzymes |
| 07/26/2001 | CA2397904A1 Wt1 interacting protein wtip |
| 07/26/2001 | CA2397901A1 Cbp86, a sperm specific protein |
| 07/26/2001 | CA2397861A1 Vaccination against canine herpesvirosis and vaccines therefor |
| 07/26/2001 | CA2397838A1 Sperm specific proteins |
| 07/26/2001 | CA2397835A1 Polypeptides with therapeutic activity and methods of use |
| 07/26/2001 | CA2397833A1 Novel haptotactic peptides |
| 07/26/2001 | CA2397783A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 07/26/2001 | CA2397617A1 Novel human nucleic acid molecules and polypeptides encoding cation channels |
| 07/26/2001 | CA2397571A1 Apoptin-associating protein |
| 07/26/2001 | CA2397324A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 07/26/2001 | CA2396979A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | CA2396969A1 Transgenic goat producing milk containing human granulocyte-colony stimulating factor |
| 07/26/2001 | CA2396898A1 Methods and compositions to modulate expression in plants |
| 07/26/2001 | CA2396307A1 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 07/26/2001 | CA2396283A1 Human cystine knot polypeptide |
| 07/26/2001 | CA2395770A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 07/26/2001 | CA2395763A1 Methods and materials relating to semaphorin-like polypeptides and polynucleotides |
| 07/26/2001 | CA2395749A1 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides |
| 07/26/2001 | CA2395736A1 Novel nucleic acids and polypeptides |
| 07/26/2001 | CA2395594A1 Process for the purification of antithrombin-iii |
| 07/26/2001 | CA2395489A1 Process for the purification of antothrombin-iii |
| 07/26/2001 | CA2395443A1 Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2369355A1 Toxicant-induced differential gene expression |
| 07/26/2001 | CA2365610A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | CA2332208A1 Pharmacophore models for, methods of screening for, and identification of the cytochrome p-450 inhibitory potency of neurokinin-1 receptor antagonists |
| 07/25/2001 | EP1118668A1 Transduction of recombinases for inducible gene targeting |
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP1118662A2 Apoptin-associating protein |
| 07/25/2001 | EP1118661A1 T cell receptor libraries |
| 07/25/2001 | EP1118660A1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 07/25/2001 | EP1118621A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/25/2001 | EP1118620A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/25/2001 | EP1118619A1 Method to identify agents active against HCV by using the structure coordinates of hepatitis C virus protease |
| 07/25/2001 | EP1118618A1 Monitor protein for measuring phosphorylation of protein |
| 07/25/2001 | EP1118334A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/25/2001 | EP1117842A1 Methods for selecting prostate cancer treatments and treating prostate cancer |
| 07/25/2001 | EP1117837A2 Methods and compositions for the diagnosis and therapy of prostate cancer |
| 07/25/2001 | EP1117824A1 Use of s-ydcb and b-ydcb, essential bacterial genes |
| 07/25/2001 | EP1117819A1 Plants and plant cells encoding the wildtype cop1 gene and the coil domain thereof |
| 07/25/2001 | EP1117818A2 Maize promoters |
| 07/25/2001 | EP1117817A2 Therapeutically active proteins in plants |
| 07/25/2001 | EP1117813A1 Geminivirus resistant transgenic plants |
| 07/25/2001 | EP1117807A2 Protective recombinant haemophilus influenzae high molecular weight proteins |
| 07/25/2001 | EP1117805A2 Modified tgf-beta superfamily proteins |
| 07/25/2001 | EP1117804A2 Chimaeric proteins between members of tgf-beta superfamily |
| 07/25/2001 | EP1117803A1 Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus |
| 07/25/2001 | EP1117800A2 Anti-mitotic agents and processes |
| 07/25/2001 | EP1117799A1 Novel strains of the bacillus subtilis group for food fermentation |
| 07/25/2001 | EP1117798A1 Fungal transcriptional activator prtt from aspergillus niger, useful in methods for producing polypeptides |
| 07/25/2001 | EP1117797A2 Rna-associated proteins |
| 07/25/2001 | EP1117796A2 Calcium channel alpha-2/delta gene |
| 07/25/2001 | EP1117795A2 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 07/25/2001 | EP1117794A2 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 |
| 07/25/2001 | EP1117793A2 Secretory protein - zsig48 |
| 07/25/2001 | EP1117792A2 Bone marrow-derived serum proteins |
| 07/25/2001 | EP1117791A2 Cancer associated antigens and uses therefor |
| 07/25/2001 | EP1117790A2 Human carbohydrate-associated proteins |
| 07/25/2001 | EP1117789A2 Synthetic peptides having fgf receptor affinity |
| 07/25/2001 | EP1117788A1 PTANs: TESTIS SPECIFIC PROTEINS EXPRESSED IN PROSTATE CANCER |
| 07/25/2001 | EP1117787A2 Slgp protein and nucleic acid molecule and uses therefor |
| 07/25/2001 | EP1117786A2 Tmof receptor and uses thereof |
| 07/25/2001 | EP1117785A1 Human kinesin-like motor protein |
| 07/25/2001 | EP1117784A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 07/25/2001 | EP1117783A1 Gene expressed in prostate cancer |
| 07/25/2001 | EP1117782A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 07/25/2001 | EP1117781A2 Human membrane channel proteins |